.png){kind=spacer}
Protein Misfolding and Degenerative Diseases
Amporin is focused on developing a new class of therapies for degenerative diseases associated with protein misfolding and aggregation, including Parkinson's disease (PD), Alzheimer's disease (AD), Type 2 diabetes (T2D), amyotrophic lateral sclerosis (ALS), Huntington's disease (HD), and numerous rare diseases. Together, these diseases affect hundreds of millions of people worldwide, cause millions of deaths each year, and impose an enormous and rapidly growing social and economic burden as populations continue to age.
Many of these conditions are now associated with the misfolding and aggregation of specific proteins or peptides, such as α-synuclein (αSyn), β-amyloid (Aβ), tau, IAPP, TDP-43, and mutant huntingtin (mHtt). Despite decades of research and billions of dollars invested in drug development, treatment options remain very limited. Most approved therapies provide short-term symptomatic relief, while a small number have demonstrated only a modest slowing of disease progression, highlighting the urgent need for new therapeutic approaches.
.png)
Common Pathology
In addition to protein misfolding and aggregation, these diseases share a remarkably similar pattern of pathology, typically characterized by:
- Toxic soluble oligomers
- Membrane perforation
- Calcium dysregulation
- Aberrant calcium signalling
- Loss of cellular function
- Cellular and oxidative stress
- Mitochondrial dysfunction
- ATP depletion and energy deficiency
- Loss of cellular homeostasis
- Apoptosis and necrosis
- Progressive degeneration
- Chronic inflammation
.png)
The remarkable similarity of all these pathological features across different diseases associated with different proteins raises a fundamental question: what common mechanism, if any, links protein misfolding to this shared pattern of cellular dysfunction and degeneration?
Toxic Pores as a Common Cause of Disease
Growing evidence suggests that the misfolded oligomeric forms of many disease-associated proteins form annular pore-like structures within cell and mitochondrial membranes. These pores are highly toxic to cells and closely resemble bacterial pore-forming toxins such as α-hemolysin in both their structure and their pathological effects, including membrane perforation, uncontrolled calcium influx, cellular and oxidative stress, mitochondrial dysfunction, loss of homeostasis, and progressive cell death and degeneration.
.png)
The Toxic Pore Hypothesis proposes that membrane perforation by these toxic pores provides the mechanistic link between protein misfolding and the common pattern of pathology observed across many degenerative diseases:
- Protein misfolding: Disease-associated proteins misfold and self-assemble into toxic soluble oligomers.
- Membrane perforation: Soluble oligomers form toxic annular pores that perforate cell and mitochondrial membranes.
- Uncontrolled calcium influx: Membrane perforation allows uncontrolled calcium influx, causing calcium overload, aberrant calcium signalling, and initial loss of cellular function.
- Mitochondrial dysfunction: Sustained calcium influx overloads the mitochondria, causing mitochondrial dysfunction, oxidative stress, ATP depletion, and energy deficiency.
- Loss of homeostasis: ATP depletion and energy deficiency cause progressive loss of cellular homeostasis and function.
- Cell death and degeneration: Loss of homeostasis ultimately leads to progressive cell death and degeneration, chronic inflammation, and disease progression.
Taken together, this sequence provides a mechanistic framework linking protein misfolding to the common pattern of pathology observed across many degenerative diseases.
In essence, toxic pores create an ionic short circuit through cell and mitochondrial membranes, causing calcium to leak into the cell and overload the mitochondria. Sustained calcium overload impairs mitochondrial function and energy production, leading to progressive loss of cellular homeostasis and ultimately cell death.
By simple analogy, breaching the hull of a boat causes water to leak into the boat and flood the engine. This causes the engine to burn out and fail so that it can no longer pump excess water out of the boat and maintain buoyancy, therefore the boat sinks.
The Toxic Pore Hypothesis has an important implication. Misfolded protein oligomers must first interact with membranes before they can disrupt the cells and organelles they surround. By damaging cell and mitochondrial membranes, toxic pores disrupt ionic gradients, calcium homeostasis, and normal cellular function. From this perspective, many degenerative protein misfolding diseases can be viewed fundamentally as disorders of membrane integrity and function.
Similar Pores, Different Membranes, Tissues and Diseases
Different misfolded protein oligomers do not necessarily target the same biological membranes. Instead, different oligomers appear to preferentially interact with different membranes in different cells and tissues throughout the brain or body.
.png)
This selective membrane targeting helps explain why different protein misfolding disorders affect different cells, tissues, organs, and physiological systems. Although the pores themselves may be structurally and functionally similar, key differences in the membranes, cells, and tissues they target can lead to different patterns of cellular dysfunction, tissue injury, and clinical disease.
Supporting Evidence
The Toxic Pore Hypothesis is now supported by a substantial and growing body of evidence accumulated over more than three decades of research into multiple degenerative diseases. Evidence for the hypothesis comes from structural biology, biophysics, electrophysiology, cell biology, pathology, animal models, and clinical studies, and has been reported for many different disease-associated proteins, including α-synuclein, β-amyloid, tau, IAPP, SOD1, TDP-43, mutant huntingtin (mHtt), and prion protein (PrP), among others.
Importantly, evidence supporting the Toxic Pore Hypothesis extends from simplified membrane systems to living cells, diseased tissues, animal models, and therapeutic intervention studies.
.png)
Taken together, these findings provide six independent pillars of evidence supporting a common pathogenic mechanism in which misfolded protein oligomers form toxic pores in biological membranes, disrupt cellular homeostasis, and contribute to cellular degeneration:
1. Oligomers permeabilize liposomes, lipid vesicles, and planar lipid bilayers in vitro
Misfolded protein oligomers bind to artificial lipid bilayers, liposomes, and lipid vesicles, where they induce membrane leakage and increase membrane permeability. Electrophysiological studies using planar lipid bilayers demonstrate discrete ion-conducting currents consistent with the formation of pore-like channels. Together, these findings show that toxic oligomers are capable of directly disrupting membrane integrity and facilitating ion flux in simplified membrane systems, even in the absence of living cells, receptors, and other proteins.
2. Oligomers permeabilize cell membranes in vitro, causing calcium influx and toxicity
In cultured cells, exposure to misfolded protein oligomers causes membrane permeabilization, uncontrolled calcium influx, calcium overload, and cellular toxicity. These effects have been demonstrated using calcium-sensitive fluorescent dyes, electrophysiology, membrane-impermeable tracers, and cell viability assays. Together, these findings provide a direct mechanistic link between membrane perforation and the early stages of cellular dysfunction.
3. Annular pore-like channels are observed by EM and AFM in vitro, and in computer simulations
Molecular dynamics simulations have shown that misfolded protein oligomers can spontaneously assemble into stable annular pore-like structures within lipid membranes. Consistent with these predictions, electron microscopy and atomic force microscopy studies have visualized ring-shaped pore-like assemblies formed by several disease-associated proteins, including α-synuclein, β-amyloid, IAPP, and tau. These structures closely resemble bacterial pore-forming toxins in both size and morphology.
4. Annular pore-like channels are observed in animal models and ex vivo disease tissues
Importantly, annular pore-like structures are not restricted to artificial membrane systems. Similar annular pore-like structures have been reported in animal models and ex vivo diseased tissues using immunohistochemistry, electron microscopy, and conformation-specific antibodies, supporting the view that pore-like assemblies can occur under disease-relevant conditions. The pathological consequences predicted by the Toxic Pore Hypothesis, including calcium dysregulation, mitochondrial dysfunction, oxidative stress, and degeneration, have also been observed in these systems.
5. Oligomer/pore inhibitors protect and restore cell viability in vitro
Multiple independent studies have shown that compounds capable of preventing oligomer formation, blocking membrane binding, inhibiting pore formation, stabilising membranes, or reducing calcium influx can significantly reduce cellular toxicity. In many cases, these interventions restore calcium homeostasis, improve mitochondrial function, and increase cell survival. These findings support the view that oligomer- and pore-mediated membrane damage contributes directly to pathology rather than representing a purely secondary consequence of disease.
6. Oligomer/pore inhibitors protect and rescue animal models of disease
Perhaps most importantly, compounds that inhibit oligomer toxicity or reduce pore-mediated membrane damage have demonstrated efficacy in animal models of multiple degenerative diseases. These interventions have been shown to reduce pathological changes, improve neuronal survival, restore behavioural function, and rescue disease phenotypes in vivo. Such studies provide proof-of-concept that toxic oligomers, pores, and pore-mediated membrane damage are therapeutically actionable targets.